Revised SPC: Tivicay (dolutegravir) film-coated tablets

SPC now details the paediatric licence extension. It is approved, in combination with other antiretrovirals, for the treatment of HIV in children from 6 years old, weighing at least 14kg. A new dispersible formulation was also approved for use in the EU recently.

Source:

electronic Medicines compendium